Kezar Life Sciences (KZR) Cash & Equivalents (2021 - 2025)
Historic Cash & Equivalents for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $38.9 million.
- Kezar Life Sciences' Cash & Equivalents rose 1169.6% to $38.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.9 million, marking a year-over-year increase of 1169.6%. This contributed to the annual value of $41.7 million for FY2024, which is 1762.6% up from last year.
- As of Q3 2025, Kezar Life Sciences' Cash & Equivalents stood at $38.9 million, which was up 1169.6% from $34.4 million recorded in Q2 2025.
- Kezar Life Sciences' Cash & Equivalents' 5-year high stood at $105.4 million during Q2 2022, with a 5-year trough of $22.9 million in Q1 2021.
- In the last 5 years, Kezar Life Sciences' Cash & Equivalents had a median value of $36.1 million in 2023 and averaged $41.7 million.
- Per our database at Business Quant, Kezar Life Sciences' Cash & Equivalents soared by 29946.55% in 2022 and then crashed by 7332.78% in 2023.
- Kezar Life Sciences' Cash & Equivalents (Quarter) stood at $62.9 million in 2021, then plummeted by 35.66% to $40.5 million in 2022, then dropped by 12.27% to $35.5 million in 2023, then rose by 17.63% to $41.7 million in 2024, then decreased by 6.74% to $38.9 million in 2025.
- Its Cash & Equivalents was $38.9 million in Q3 2025, compared to $34.4 million in Q2 2025 and $37.0 million in Q1 2025.